Noble Life Sciences will be attending Diversity Alliance For Science 2019 East Coast Conference, a very interactive meeting where corporations and small and/or divers businesses build relationships to drive inclusive procurement practices. Noble is proud to be graduating from 2018 – 2019 mentorship program and feel fortunate to be mentored by Eli Lilly.
Noble is a preclinical CRO providing discovery to GLP safety toxicology studies to support small molecule, biologic, and cell/gene therapy development using a wide variety of in vitro and in vivo preclinical models. With our capabilities spanning from small to large animals, flow cytometry, live animal imaging, we could be your turnkey CRO partners in taking your preclinical program from discovery to IND enabling studies at an accelerated speed.
Interested in learning more about our services and how we can help speeding up your preclinical program, Srujana Cherukuri, CEO of Noble will be at the conference on June 5th – 6th , 2019, use the form in this page to schedule a in-person meeting at the conference on June 5th – 6th or telephone meeting in the week of June 10.